ZOKINVY

Zokinvy is the first and only treatment for progeria and PDPL that targets the cause and symptoms of progeria and PDPL. It interrupts a key step in the disease process, helping to block progerin and progerin-like proteins from building up and damaging cells... Zokinvy interrupts a key disease process in young people with progeria and processing-deficient progeroid laminopathies (PDPL), helping to block progerin and progerin-like proteins from building up and damaging cells

Also known as: Eiger BioPharmaceuticals